The pulmonary devices market was valued at US$ 18,598.56 million in 2019 and is projected to reach US$ 39,965.01 million by 2027; it is expected to grow at a CAGR of 10.1%from 2020 to 2027.
Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract. The pulmonary devices market growth is mainly attributed to the rising number of COVID-19 cases worldwide and increasing prevalence of respiratory diseases. Moreover, strategic activities by the manufacturers such as type innovation, type launches, and approvals, as well as R&D investment for advancements in ventilatorsare further expected to foster the market growthduring the forecast period. However, unfavorable reimbursement scenario limitsthe growth of the market.
Ask for sample PDF copy at: https://www.theinsightpartners.com/sample/TIPRE00012649/
The growth of the pulmonary devicesmarket is attributed to factors such asrising number of COVID-19 cases worldwide and increasing prevalence of respiratory diseases. However, the unfavorable reimbursement scenario associated with the respiratory devicesrestrain the growth of the market.Koninklijke Philips N.V, Caire Inc. (Chart Industries), Inogen Inc., Invacare Corporation, O2 Concepts, Nidek Medical Types, Inc., Drive DeVilbiss International, GCE Group, Besco Medical, and Inova labs Inc. (ResMed) are among the leading companies operating in the global pulmonary devicesmarket.
The global pulmonary devicesmarket,based on type, is segmented into therapeutic devices, consumables and accessories, diagnostic devices, and monitoring devices.The therapeutic devicessegment held the largest share of the market in 2019, and this growth is ascribed tothe increasing demand of inhalers and nebulizers by patients suffering with asthma and chronic obstructive pulmonary disorders. However, the consumables and accessoriessegment is estimated to register the highest CAGR during the forecast period. Also, the impact of the COVID-19 crisis is expected to further accelerate the growth of the respiratory devices market.Critical care devices are being manufactured in increased quantities to meet growing demand. The state of affairs resulting from the pandemic has resulted in alliances between healthcare and non-healthcare industries to manufacture respiratory care devices. Moreover, the US FDA has authorized the use of CPAP and similar devices to help cover the forecasted shortage of ventilators in COVID-19 treatment.
The impact of the COVID-19 crisis is expected to further accelerate the growth of the respiratory devices market in Europe. For instance, Apex Medical is focused towards providing CPAP ventilator solutions as COVID-19 treatment alternative as per the British Medicines and Medical Products Regulatory Agency (MHRA) to the patients with respiratory insufficiency. Additionally, In the United Kingdom (UK), for example, the government has asked automobile manufacturers including Ford, Honda, and Rolls-Royce to temporarily shift part of their assembly line focus from cars to developing respiratory equipment.
Infectious respiratory diseases directly drive demand for respiratory care. COVID-19 is the most recent and significant of these diseases; the pandemic has resulted in a surge in demand for personal protection equipment and ventilators, among others. The demand for ventilators has also grown due to the COVID-19 outbreak, resulting in governmental and industrial support for driving the pace of manufacturing. As of now, the virus has infected more than a quarter of a million people globally. With the continued spread of this virus, which can cause pneumonia and difficulty breathing, hospitals are facing a limited supply of ventilators. For instance, in Italy, hospitals have been overwhelmed with patients in respiratory failure, and medical staffs have to make difficult life-or-death decisions about which patients receive ventilators. As the shortage and prevalence of respiratory diseases increase, the global pulmonary device market is expected to grow at a steady pace.
Inquiry for Discount at: https://www.theinsightpartners.com/discount/TIPRE00012649/
Application-Based Insights
Based on application, the pulmonary devices marketis segmented into COPD, asthma, sleep apnea, infectious disease and others. The COPD segment held the largest share of the market in 2019. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.Chronic obstructive pulmonary disorder commonly referred to, as COPD is a group of progressive lung disorders that commonly include bronchitis and emphysema. People having COPD usually suffer from both of the diseases. Smoking tobacco is known to be the top cause of COPD. In addition, long-term exposure by individuals to chemical irritants may also lead to COPD. The disease usually takes a long time to develop and establish.
End User-Based Insights
Based on end user, the pulmonary devices marketis segmented into hospitals, home care settings and ambulatory care centers. The hospitals segment held the largest share of the market in 2019; however, home care settings segment is estimated to register the highest CAGR during the forecast period.Hospitals segment is estimated to hold a considerable share as majority of the patients in emerging and developed countries prefer visiting hospitals for any kind of health-related problem. Further, the increasing number of hospitals and adoption of advanced diagnostic platforms offer lucrative opportunities for the growth of the market for the hospital segment.
Strategic Insights
Product launches, mergersand acquisitions, collaborations, and expansionsarethe commonly adopted strategies by various companies to expand their footprint worldwide and meet the growing demandby expanding theirrespective product portfolios.The players operating in the pulmonary devices marketadopted the product innovationsstrategy to cater to changing customer demand worldwide, which also permits them to maintain their brand name globally.
Purchase Copy of This Report at: https://www.theinsightpartners.com/buy/TIPRE00012649/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.